미국 프리마켓 특징주, 이슈 • $NVDA +0.30% : 중국, 빠르면 이번 분기 내 일부 H200 칩 구매 승인 예정 • $JEF -2.75% : 실적은 호조였으나, 투자자들은 First Brands 익스포저 관련 손실에 주목 • $STZ +2.0% : 시장 예상 상회 실적 발표 • $APLD +4.6% : 조정 EPS 및 매출 모두 예상치 상회 • $RTX +4.5% / $LMT +7.9% / $NOC +8.4% : 트럼프, 국방 예산을 기존 1.0조 달러 → 1.5조 달러로 증액해야 한다고 발언 • $ABBV -1.1% : 연간 조정 EPS 가이던스 하향 : $RVMD -7.3%, 인수설 부인 영향 • $GOOGL +1.1% : Cantor Fitzgerald, 투자의견 ‘중립’ → ‘비중확대’ 상향 • $MQ -9.5% : Mizuho, 투자의견 ‘시장수익률 상회’ → ‘중립’ 하향 • $AA -4.0% : JPMorgan, 투자의견 ‘중립’ → ‘비중축소’ 하향 • $NKE -1.1% : Needham, 투자의견 ‘매수’ → ‘보유’ 하향 MTS, @MSX_CN 로 국장, 미장 깔짝깔짝

MARKET HIGHLIGHTS AUTOS: 🔸 GM & Ford drop as Trump imposes 25% import tax on foreign cars (effective April 3); European & Asian automakers also down. 🔸 S&P Changes: Cava ( $CAVA) replaces Altair ( $ALTR) in S&P MidCap 400 (March 31) after Siemens acquires Altair. 🔸 Crypto: GameStop ( $GME) plans $1.3B convertible notes offering to buy Bitcoin. EARNINGS: 🔸 MillerKnoll ( $MLKN): Q3 EPS $0.44 in line, revenue $876.2M (miss); Q4 guide below estimates. 🔸 Nio ( $NIO): Raises $450M via share placement for EV development. 🔸 Petco ( $WOOF): Q4 EBITDA beats, but weak Q1 & FY guidance. 🔸 Steelcase ( $SCS): Q4 EPS beats; Q1 revenue & EPS guidance above estimates. INDUSTRIALS & MATERIALS: 🔸 Chemours ( $CC) upgraded at Mizuho; 🔸 Liberty Energy ( $LBRT) upgraded at Morgan Stanley. 🔸 HB Fuller ( $FUL) beats Q1 EPS, guides FY revenue lower. FINANCIALS: 🔸 Jefferies ( $JEF) Q4 EPS misses; cites challenging capital markets. HEALTHCARE: 🔸 Medicaid overpaid insurers ( $CI, $HUM, $UNH, $ELV), per WSJ. 🔸 Nkarta ( $NKTX): Q4 EPS beats, cash runway to 2029. 🔸 Soleno ( $SLNO): FDA approves Vykat XR for genetic disorder. 🔸 Zentalis ( $ZNTL): Files mixed shelf offering up to $250M. TECH & MEDIA: 🔸 $AMD downgraded at Jefferies (AI concerns, competition). 🔸 S&P Changes: Angi ( $ANGI) replaces ODP in SmallCap 600. 🔸 3D Systems ( $DDD): Q4 EPS misses, weak FY guidance. 🔸 Concentrix ( $CNXC): Q1 EPS & revenue beat, reiterates FY outlook. 🔸 OpenAI nears $40B funding at $300B valuation (Bloomberg). 🔸 Verint ( $VRNT): Q4 EPS & revenue miss, weak FY guidance.